Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 17,000 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Follow-Up Questions
Smith & Nephew PLC 的 CEO 是誰?
Mr. Deepak Nath 是 Smith & Nephew PLC 的 Chief Executive Officer,自 2022 加入公司。
SNN 股票的價格表現如何?
SNN 的當前價格為 $36.48,在上個交易日 increased 了 0.38%。
Smith & Nephew PLC 的主要業務主題或行業是什麼?
Smith & Nephew PLC 屬於 Health Care 行業,該板塊是 Health Care